Breyanzi CAR T-cells for Clatterbridge come from Bristol-Myers Squibb
- The Clatterbridge Cancer Centre NHS Foundation Trust
- North West
- Direct award
- 17 August 2026 to 18 August 2026
The Clatterbridge Cancer Centre NHS Foundation Trust bought Breyanzi CAR T-cells from Bristol-Myers Squibb Pharmaceuticals for its specialist cancer care.
Breyanzi is a CAR T-cell therapy. The purchase was commissioned through NHS England, and the products were supplied direct.
The trust awarded the £140,250 contract directly in August 2026, without a tender.
- What
- Medicines supply
- Value
- £140,250
- How it was bought
- Direct award
- Dates and next
- Aug 2026 to Aug 2026